Subcutaneous therapeutic use of dpp-4 inhibitor

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

KLEIN THOMAS,MARK MICHAEL

申请号：

NZ62497212

公开号：

NZ624972A

申请日:

2012.12.28

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

Disclosed is the use of linagliptin and one of a GLP-1 analogue having a short half-life or native GLP-1, for the manufacture of a medicament, effective in the treatment of obesity or overweight or for reducing body weight in a subject in need thereof, wherein the medicament is administered subcutaneously.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/